首页 > 市场调查报告书 > 医疗设备

市场调查报告书

商品编码

1846088

全球合约灭菌市场规模（按类型、应用、最终用户、区域范围和预测）

Global Contract Sterilization Market Size By Type (Ethylene Oxide, Gamma Irradiation), By Application (Medical Devices, Pharmaceuticals), By End-User (Hospitals And Clinics, Medical Device Companies), By Geographic Scope And Forecast

出版日期: 2025年09月22日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格

简介目录

合约灭菌市场规模及预测

合约灭菌市场预计在 2024 年达到 52.4 亿美元，在 2031 年达到 98.4 亿美元，2024 年至 2031 年的复合年增长率为 8.2%。

合约灭菌是指由专业公司代表其他公司提供产品灭菌过程的服务，主要涉及医疗保健、製药和医疗设备业。

该服务确保产品不含微生物、符合监管标准和行业要求并且可以安全使用，而无需客户投资自己的消毒设备和设施。

合约灭菌的主要应用是在医疗保健和製药领域，在这些领域，确保医疗设备、手术器材和药品等产品的安全性和有效性至关重要。

将灭菌工作外包给专业机构，可使公司专注于核心竞争力，同时确保产品符合严格的安全和品质标准。合约灭菌服务采用多种灭菌方法，包括蒸气、环氧乙烷 (EO) 灭菌和辐射灭菌，以满足特定的产品要求。

全球合约灭菌市场动态

影响全球合约灭菌市场的关键市场动态是：

关键市场驱动因素

监管要求：医疗保健和製药业对产品安全和品质的严格监管和标准推动了对可靠灭菌流程的需求，使得合约灭菌成为关键服务。根据美国食品药物管理局(FDA) 的规定，医疗设备和药品必须符合严格的安全标准，这推动了对杀菌委託服务的需求。

医疗保健和製药业的成长：医疗保健和製药业的扩张增加了对灭菌医疗设备、药品和设备的需求，从而推动了对专业灭菌服务的需求。根据世界卫生组织 (WHO) 的报告，全球医疗保健市场规模到 2023 年将达到约 12 兆美元，预计将持续成长。这种增长导致对专业灭菌服务的需求不断增加，以确保产品的安全性和有效性。

技术进步：灭菌技术的创新，例如先进的自动化和製程改进，正在提高杀菌委託服务的有效性和效率，从而推动市场成长。例如，Sterigenics International 最近推出了一套先进的环氧乙烷 (EO) 灭菌自动化系统，缩短了处理时间，提高了合规性。

外包需求不断增长：越来越多的公司将灭菌等非核心功能外包，以专注于核心竞争力，这进一步推动了对杀菌委託服务的需求。 Medistri 报告称，随着製药公司将灭菌需求外包，2024 年灭菌合约请求将大幅增加。该公司将这一成长归因于外包的策略优势，例如降低成本和更专注于核心业务活动。

主要挑战

监管合规挑战：对于合约灭菌提供者来说，满足因地区而异的复杂监管要求可能很困难，从而导致延误和营运成本增加。

依赖外部供应商：依赖第三方灭菌服务可能会带来与品管、一致性和保密相关的风险，影响客户的信任和满意度。

灵活性有限：合约灭菌提供者可能有固定的流程和时间表，这可能会限制他们的灵活性和应对力。

地理限制：偏远和欠发达地区的公司可能难以获得可靠的杀菌委託服务，从而阻碍这些地区的市场发展。

专用设备高成本：先进灭菌技术和设备的初始投资可能很大，这可能会抑制中小企业的外包并限制市场成长。

主要趋势

技术进步：自动化和低温等离子等先进灭菌技术的采用正在提升市场效率和效益。美国食品药物管理局(FDA) 报告称，到 2024 年，整合这些技术可将灭菌製程效率提高高达 25%，并降低营运成本。 Sterigenics International 等公司正在实施这些进步，以保持竞争力并满足日益增长的行业需求。

更重视永续实践：人们正明显转向环保灭菌方法和永续实践。美国环保署 (EPA) 指出，到 2024 年，灭菌承包商使用环保灭菌技术（例如减少危险化学品的使用）的比例将增加 20% (EPA, 2024)。 Medistry 最近宣布致力于更环保的实践，包括采用一种新的环保灭菌工艺。

新兴市场扩张：由于医疗保健投资的增加和对无菌产品的需求，合约灭菌市场在新兴市场正在显着扩张。世界卫生组织 (WHO) 报告称，到 2024 年，亚太地区等地区医疗基础设施的改善和医疗服务可及性的提高将推动合约灭菌服务的年增长率达到 7%。 SGS 和 Steris 等主要企业正在利用这一成长机会，扩大业务。

By outsourcing sterilization to specialized providers, companies can focus on their core competencies while ensuring that their products meet strict safety and quality standards. Contract sterilization services use various methods, including steam, ethylene oxide (EO), and radiation, to meet specific product requirements.

Global Contract Sterilization Market Dynamics

The key market dynamics that are shaping the global contract sterilization market include:

Key Market Drivers

Regulatory Requirements: Stringent regulations and standards for product safety and quality in the healthcare and pharmaceutical industries drive the need for reliable sterilization processes, making contract sterilization a critical service. According to the U.S. Food and Drug Administration (FDA), medical devices and pharmaceutical products must meet rigorous safety standards, which has increased the demand for contract sterilization services.

Growth in Healthcare and Pharmaceuticals: Expanding healthcare and pharmaceutical sectors increase the demand for sterilized medical devices, drugs, and equipment, fueling the need for specialized sterilization services. The global healthcare market was valued at approximately USD 12 Trillion in 2023, with growth expected to continue, as reported by the World Health Organization (WHO). This growth fuels the need for specialized sterilization services to ensure product safety and efficacy

Technological Advancements: Innovations in sterilization technologies, such as advanced automation and improved processes, enhance the effectiveness and efficiency of contract sterilization services, driving market growth. For instance, Sterigenics International recently introduced advanced automation systems for ethylene oxide (EO) sterilization, improving processing times and compliance.

Increasing Demand for Outsourcing: Companies are increasingly outsourcing non-core activities like sterilization to focus on their primary business functions, further boosting the demand for contract sterilization services. Medistri has reported a significant increase in contract sterilization requests in 2024, driven by pharmaceutical companies outsourcing their sterilization needs. The company attributed this rise to the strategic benefits of outsourcing, including cost savings and enhanced focus on core business activities.

Key Challenges:

Regulatory Compliance Challenges: Navigating complex and varying regulatory requirements across different regions can be challenging for contract sterilization providers, potentially causing delays and increasing operational costs.

Dependence on External Providers: Relying on third-party sterilization services may pose risks related to quality control, consistency, and confidentiality, impacting client trust and satisfaction.

Limited Flexibility: Contract sterilization providers may have fixed processes and schedules, which can limit flexibility and responsiveness to clients' changing needs or urgent requirements.

Geographic Limitations: Companies in remote or less developed regions may face difficulties accessing reliable contract sterilization services, constraining market growth in these areas.

High Costs of Specialized Equipment: The initial investment in advanced sterilization technologies and equipment can be substantial, which may deter smaller firms from outsourcing and limit market growth.

Key Trends

Technological Advancements: The adoption of advanced sterilization technologies, such as automation and low-temperature plasma, is enhancing market efficiency and effectiveness. The U.S. Food and Drug Administration (FDA) reported in 2024 that the integration of these technologies could increase sterilization process efficiency by up to 25% and reduce operational costs. Companies like Sterigenics International are implementing these advancements to stay competitive and meet growing industry demands.

Increasing Focus on Sustainable Practices: There is a notable shift towards environmentally friendly sterilization methods and sustainable practices. The Environmental Protection Agency (EPA) highlighted in 2024 that the use of eco-friendly sterilization techniques, such as reducing hazardous chemicals, has increased by 20% among contract sterilization providers (EPA, 2024). Medistri has recently announced its commitment to greener practices, including new eco-friendly sterilization processes.

Expansion in Emerging Markets: The contract sterilization market is expanding significantly in emerging markets due to increased healthcare investments and demand for sterilized products. The World Health Organization (WHO) reported in 2024 that healthcare infrastructure improvements and growing access to medical services in regions like Asia-Pacific are driving a 7% annual growth rate in contract sterilization services. Key players like SGS and Steris are expanding their operations to capitalize on this growth.

Global Contract Sterilization Market Regional Analysis

Here is a more detailed regional analysis of the global contract sterilization market:

North America

North America dominating the global contract sterilization market. North America's advanced healthcare infrastructure supports a high demand for sterilized medical devices and pharmaceuticals. The U.S. boasts a vast network of healthcare facilities and research institutions, creating a robust market for contract sterilization services to ensure product safety and efficacy.

The U.S. Food and Drug Administration (FDA) enforces stringent safety and quality standards for medical products, driving the need for reliable and compliant sterilization processes. These regulations ensure that contract sterilization providers adhere to high standards, fostering trust and consistency in the market.

Companies like Sterigenics International and Steris are key players in North America's contract sterilization market. They leverage advanced sterilization technologies, such as automation and innovative methods, to meet the growing demand and maintain their competitive edge in the industry.

Asia Pacific

The Asia-Pacific region is experiencing rapid growth in the contract sterilization market. Increased healthcare investments in the Asia-Pacific region are driving the growth of the contract sterilization market. Countries like China and India are significantly investing in healthcare infrastructure, enhancing their ability to support advanced sterilization services and improve product safety.

The expansion of healthcare access across the region is leading to higher demand for sterilized medical products. Improved access to healthcare facilities and services in countries such as Japan and South Korea is fueling the need for reliable and compliant sterilization solutions.

Major companies like SGS are expanding their operations in the Asia-Pacific region to capitalize on the growing market. By establishing new facilities and enhancing service offerings, these companies are positioned to meet the increasing demand and support the region's expanding healthcare needs.

Global Contract Sterilization Market: Segmentation Analysis

The Global Contract Sterilization Market is segmented based on Type, Application, End-User, And Geography.

Contract Sterilization Market, By Application

Medical Devices

Pharmaceuticals

Food and Beverage

Cosmetics

Based on Application, the Global Contract Sterilization Market is bifurcated into Medical Devices, Pharmaceuticals, Food and Beverage, and Cosmetics. The medical devices segment dominates the contract sterilization market due to the stringent requirements for sterilized equipment and the high volume of devices needing sterilization to ensure patient safety and regulatory compliance. The pharmaceuticals sector is the second most rapidly growing segment, driven by increased demand for sterile drug products and biologics, as well as the expansion of the pharmaceutical industry and evolving regulatory standards.

Contract Sterilization Market, By Type

Ethylene Oxide

Gamma Irradiation

Electron Beam

Plasma Sterilization

Vaporized Hydrogen Peroxide

Based on Type, the Global Contract Sterilization Market is bifurcated into Ethylene Oxide, Gamma Irradiation, Electron Beam, Plasma Sterilization, and Vaporized Hydrogen Peroxide. Ethylene oxide is dominating the contract sterilization market due to its effectiveness in sterilizing heat-sensitive medical devices and pharmaceuticals, meeting the rigorous standards required by regulatory bodies. Plasma sterilization is the second most rapidly growing segment, driven by its advantages in providing low-temperature sterilization with high efficacy and minimal environmental impact, making it increasingly popular among healthcare and pharmaceutical companies.

Contract Sterilization Market, By End-User

Hospitals and Clinics

Medical Device Companies

Pharmaceutical and Biotechnology Companies

Based on End-User, the Global Contract Sterilization Market is bifurcated into Hospitals and Clinics, Medical Device Companies, and Pharmaceutical and Biotechnology Companies. The pharmaceutical and biotechnology companies segment dominates the contract sterilization market due to the high demand for sterilized drugs and biologics, driven by stringent regulatory requirements and the need for product safety. Medical device companies are the second most rapidly growing segment, experiencing increased demand for sterilized medical devices and equipment as technological advancements and regulatory standards evolve, driving growth in this sector.

Contract Sterilization Market, By Geography

North America

Europe

Asia Pacific

Rest of the World

Based on Geography, the Global Contract Sterilization Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. North America is dominating the contract sterilization market due to its well-established healthcare infrastructure, stringent regulatory standards, and high demand for sterilized medical devices and pharmaceuticals. In contrast, the Asia-Pacific region is the second most rapidly growing market, driven by rising healthcare investments, increasing healthcare access, and a growing demand for sterilized products, with the market expanding at a robust.

Key Players

The "Global Contract Sterilization Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Sterigenics, Steris Corporation, Sotera Health, E-BEAM Services, Inc., Noxilizer, Inc., Cosmed Group, Cantel Medical Corporation.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Global Contract Sterilization Market Key Developments

In August 2023, Johnson & Johnson unveiled a new partnership with a contract sterilization firm to integrate automated sterilization processes into their manufacturing operations, aimed at increasing throughput and ensuring stringent compliance with industry standards.
In November 2023, Cantel Medical introduced an upgraded contract sterilization service featuring enhanced monitoring systems for better traceability and validation of sterilization processes, addressing growing regulatory demands.
In March 2024, 3M Company announced the expansion of its contract sterilization services to include a new facility focused on providing sterilization solutions for the emerging biopharmaceutical sector, responding to the increasing demand for sterile processing in drug manufacturing.

1. Introduction

Market Definition
Market Segmentation
Research Methodology

2. Executive Summary

Key Findings
Market Overview
Market Highlights

3. Market Overview

Market Size and Growth Potential
Market Trends
Market Drivers
Market Restraints
Market Opportunities
Porter's Five Forces Analysis

4. Contract Sterilization Market, By Type

Overview
Ethylene Oxide
Gamma Irradiation
Electron Beam
Plasma Sterilization
Vaporized Hydrogen Peroxide

5. Contract Sterilization Market, By Application

Overview
Medical Devices
Pharmaceuticals
Food and Beverage
Cosmetics

6. Contract Sterilization Market, By End-User

Overview
Hospitals and Clinics
Medical Device Companies
Pharmaceutical and Biotechnology Companies

7. Regional Analysis

Overview
North America
United States
Canada
Mexico
Europe
United Kingdom
Germany
France
Italy
Asia-Pacific
China
Japan
India
Australia
Latin America
Brazil
Argentina
Chile
Middle East and Africa
South Africa
Saudi Arabia
UAE

8. Market Dynamics

Market Drivers
Market Restraints
Market Opportunities
Impact of COVID-19 on the Market

9. Competitive Landscape

Key Players
Market Share Analysis

10. Company Profiles

Overview
Sterigenics
Steris Corporation
Sotera Health
E-BEAM Services, Inc.
Noxilizer, Inc.
Cosmed Group
Cantel Medical Corporation
Beta-Gamma-Service GmbH & Co. KG
Nelson Laboratories
Life Science Outsourcing, Inc

11. Market Outlook and Opportunities

Emerging Technologies
Future Market Trends
Investment Opportunities

12. Appendix

List of Abbreviations
Sources and References

02-2729-4219

+886-2-2729-4219

License/价格

全球合约灭菌市场规模（按类型、应用、最终用户、区域范围和预测）

Global Contract Sterilization Market Size By Type (Ethylene Oxide, Gamma Irradiation), By Application (Medical Devices, Pharmaceuticals), By End-User (Hospitals And Clinics, Medical Device Companies), By Geographic Scope And Forecast

合约灭菌市场规模及预测

全球合约灭菌市场动态

关键市场驱动因素

目录

第一章 引言

第二章执行摘要

第三章 市场概况

4. 合约灭菌市场（按类型）

第五章合约灭菌市场：依应用

第六章 合约灭菌市场（依最终用户）

第七章区域分析

第八章市场动态

第九章 竞争态势

第十章：公司简介

第十一章 市场展望与机会

第十二章 附录

Contract Sterilization Market Size And Forecast